- This topic is empty.
-
Posts
-
-
This page lists the main topics and stocks discussed on Mad Money with Jim Cramer aired on September 26, 2025, with links to CNBC articles, videos, and English transcripts.
2025年9月26日放送の 「Mad Money with Jim Cramer」 で取り上げられた主な話題・銘柄を、CNBCの記事・動画・英文トランスクリプトへのリンクとともに一覧化しています。
(1) Cramer’s week ahead: Nonfarm payroll report, earnings from Paychex and Nike (https://www.cnbc.com/2025/09/26/cramer-week-jobs-report-paychex-nike-earnings.html)
- CNBC’s Jim Cramer on Friday told investors what to look out for next week on Wall Street, including the latest’s nonfarm payroll report and earnings from Paychex and Nike.
- “The employment number lords over all other entries here. Call me concerned because I know that some parts of the economy — anything connected to this data center — are overheating. But another part, autos homes, retailers, are dreadful,” he said.
“Bottom Line: The employment number lords over all other major happenings next week.. The data center economy is overheating, but the consumer economy is dreadful.”
(2) [No Video Clip for non-Club members] Jim Cramer gives his take on when to buy Credo Technology (https://www.cnbc.com/video/2025/09/26/jim-cramer-gives-his-take-on-when-to-buy-credo-technology.html)
CNBC’s Jim Cramer talks about Credo Technology’s business, stock price and what investors should know before considering investing in the company.
Ticker: CRDO
“Bottom Line: CRDO has strong products and financials – wait for a dip before loading up.”
(3) [No Video Clip for non-Club members] Jim Cramer says ‘I’m not a fan of Rezolve AI here’ (https://www.cnbc.com/video/2025/09/26/jim-cramer-says-im-not-a-fan-of-rezolve-ai-here.html)
CNBC’s Jim Cramer breaks down what he thinks of Rezolve AI and why it’s important to do your homework when investing.
Ticker: RZLV
“Bottom Line: When it comes to a play in AI, hype doesn’t replace hard numbers.”
(4) Executive Interview: Johnson & Johnson CEO is optimistic about pharma innovation in the U.S. despite industry challenges from the Trump administration (https://www.cnbc.com/2025/09/26/johnson-johnson-ceo-is-optimistic-about-pharma-innovation-in-the-us-.html)
- In a Friday interview with CNBC’s Jim Cramer, Johnson & Johnson CEO Joaquin Duato expressed optimism about the future of pharmaceutical innovation in the U.S., even as the Trump administration slaps tariffs on imported drugs and cuts research funding.
- “We’ve been through ups and downs at Johnson & Johnson over our 140 years of history. I’m an optimist,” Duato said. “I believe in the strength of the life science industry in this country. I think that we will remain the leaders as we are today, the undisputed leaders in healthcare innovation.”
Ticker: JNJ
(5) Cramer’s Lightning Round: ONEOK is a buy (https://www.cnbc.com/2025/09/26/cramers-lightning-round-oneok-is-a-buy.html)
- D-Wave Quantum: “I want you to take out your cost basis so you can let the rest run.”
- American Electric Power: ”[buy, buy, buy!]”
- ONEOK: “I think that’s a buy, can’t believe it’s this low.”
Ticker: QBTS, AEP, OKE
(6) [No Video Clip for non-Club members] Why Jim Cramer says ‘Costco is one of the best performers of all time’ (https://www.cnbc.com/video/2025/09/26/why-jim-cramer-says-costco-is-one-of-the-best-performers-of-all-time.html)
CNBC’s Jim Cramer discusses what he think of Costco’s business, stock price and outlook.
Ticker: COST
Other Stocks Discussed (calls with audience)/ この日の放送で取り上げられたその他の銘柄（視聴者からの電話）: Bristol Myers (BMY) [JNJ is doing a better job than Bristol], MNTN Inc. (MNTN) [The product is good.. and when I saw it all the way down here, I said maybe I should gear up], Sales force (CRM) [Even though it’s down 27%m I’m going to reserve judgement until I do more work]
Ref: Links related to this episode /参考: この日の放送に関するその他のサイトへのリンク :
- Podcast at Spotify (Sound /音声）
- InternetArchive（Video & Texts per minute /1分毎のビデオ＆テキスト）
****************************
Previous Episode/ 前回のエピソード Next Episode / 次回のエピソード
-
- The forum ‘Mad Money Stock Archive (ジム・クレイマーの銘柄紹介)’ is closed to new topics and replies.